FDA Halts Diabetes Cell Tx Trial; Europe's Obesity Epidemic; Acromegaly Fractures
(MedPage Today) -- The FDA placed a clinical hold on Vertex's investigational diabetes cell therapy VX-880, saying the company didn't have enough evidence to support a treatment dose increase. (Fierce Biotech)
A study from England found that surgeons...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Acromegaly | Biotechnology | Diabetes | Eating Disorders & Weight Management | Endocrinology | Epidemics | Epidemiology | Obesity | Orthopaedics | Study